As of 2026-07-20, the EV/EBITDA ratio of Proteome Sciences PLC (PRM.L) is -12.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRM.L's latest enterprise value is 22.28 mil GBP. PRM.L's TTM EBITDA according to its financial statements is -1.74 mil GBP. Dividing these 2 quantities gives us the above PRM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 24.9x | 17.8x |
| Forward P/E multiples | 11.5x - 14.8x | 12.1x |
| Fair Price | (9.60) - (11.17) | (11.24) |
| Upside | -580.2% - -658.5% | -662.1% |
| Date | EV/EBITDA |
| 2026-07-13 | -12.78 |
| 2026-07-10 | -12.32 |
| 2026-07-09 | -12.20 |
| 2026-07-08 | -11.99 |
| 2026-07-07 | -11.57 |
| 2026-07-06 | -12.15 |
| 2026-07-03 | -11.36 |
| 2026-07-02 | -12.09 |
| 2026-07-01 | -12.11 |
| 2026-06-30 | -12.81 |
| 2026-06-29 | -12.47 |
| 2026-06-26 | -11.78 |
| 2026-06-25 | -12.17 |
| 2026-06-24 | -11.78 |
| 2026-06-23 | -11.82 |
| 2026-06-22 | -11.84 |
| 2026-06-19 | -11.92 |
| 2026-06-18 | -11.99 |
| 2026-06-17 | -11.99 |
| 2026-06-16 | -12.03 |
| 2026-06-15 | -12.60 |
| 2026-06-12 | -12.01 |
| 2026-06-11 | -11.88 |
| 2026-06-10 | -12.77 |
| 2026-06-09 | -12.77 |
| 2026-06-08 | -12.19 |
| 2026-06-05 | -12.11 |
| 2026-06-04 | -12.01 |
| 2026-06-03 | -12.81 |
| 2026-06-02 | -11.63 |
| 2026-06-01 | -13.35 |
| 2026-05-29 | -13.39 |
| 2026-05-28 | -11.57 |
| 2026-05-27 | -12.01 |
| 2026-05-26 | -11.67 |
| 2026-05-22 | -11.90 |
| 2026-05-21 | -11.78 |
| 2026-05-20 | -11.80 |
| 2026-05-19 | -11.75 |
| 2026-05-18 | -11.82 |
| 2026-05-15 | -12.22 |
| 2026-05-14 | -12.51 |
| 2026-05-13 | -12.53 |
| 2026-05-12 | -12.32 |
| 2026-05-11 | -13.06 |
| 2026-05-08 | -11.69 |
| 2026-05-07 | -11.59 |
| 2026-05-06 | -11.59 |
| 2026-05-05 | -12.09 |
| 2026-05-01 | -11.80 |